MRNX
Leveraged Long
Defiance Daily Target 2X Long MRNA ETF
Daily Target 2X Long MRNA (Moderna, Inc.) ETF
Overview
The Defiance Daily Target 2X Long MRNA ETF (MRNX) provides investors with amplified long exposure to Moderna, Inc. (NASDAQ: MRNA), a biotechnology company focused on the development and commercialization of messenger RNA (mRNA)–based medicines and vaccines. Moderna’s proprietary mRNA platform enables the rapid design and production of therapies across a range of disease areas, including infectious diseases and other unmet medical needs.
MRNX seeks to deliver 200% of the daily performance of MRNA’s stock, offering active traders a tactical way to express short-term bullish views on biotechnology innovation, mRNA-based drug development, vaccine demand dynamics, and advancements in next-generation therapeutic platforms—without the need for a margin account.
Investment Objective
The Fund seeks daily investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Moderna, Inc. (NASDAQ: MRNA). The Fund does not seek to achieve its stated investment objective for a period other than a single trading day.
Underlying Stock: Moderna, Inc.
Moderna, Inc. is a biotechnology company focused on the discovery, development, and commercialization of medicines based on messenger RNA technology. The company’s platform enables the design of mRNA-based therapeutics and vaccines across a range of disease areas, including infectious diseases and other unmet medical needs. Moderna, Inc. is listed on the Nasdaq Stock Market and is classified within the biotechnology industry.
An investment in the ETF is not a direct investment in Moderna, Inc.
The Fund is not suitable for all investors. The Fund is designed to be utilized only by knowledgeable investors who understand the potential consequences of seeking daily leveraged (2X) investment results, understand the risks associated with the use of leverage, and are willing to monitor their portfolios frequently. The Fund is not intended to be used by, and is not appropriate for, investors who do not intend to actively monitor and manage their portfolios. The Fund pursues daily leveraged investment objectives, which means it is riskier than alternatives that do not use leverage. The Fund magnifies the performance of the Underlying Security and is designed strictly for short-term use. For periods longer than a single day, the Fund’s performance will be the result of compounded daily returns, which is very likely to differ from 200% of the return of MRNA over the same period. It is possible that investors could lose their entire principal within a single trading day.
MRNXMarket Price
Performance
| YTD | 1 Month | 3 Months | 6 Months | Since Inception | |
|---|---|---|---|---|---|
| Total Return NAV (%) | xx.xx% | 76.25% | 227.42% | 432.35% | 599.39% |
| Market Price (%) | xx.xx% | 77.33% | 230.55% | 436.20% | 604.90% |
| 1 Year | 3 Years | 5 Years | Since Inception | |
|---|---|---|---|---|
| Total Return (%) | xx.xx% | xx.xx% | xx.xx% | xx.xx% |
| Market Price (%) | xx.xx% | xx.xx% | xx.xx% | xx.xx% |
| YTD | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | Since Inception | |
|---|---|---|---|---|---|---|---|
| Total Return (NAV) (%) | — | — | — | — | — | — | — |
| Market Price (%) | — | — | — | — | — | — | — |
| 1 Year | Since Inception | |
|---|---|---|
| Total Return (NAV) (%) | — | — |
| Market Price (%) | — | — |
Fund Details
Top Holdings
| Name | Symbol | Stock Price | % Net Assets | Shares Held | Market Value |
|---|---|---|---|---|---|
| Moderna Inc Swap Cs-l | 60770K107-TRS-03/07/28-L-MRNX | $190.01 | 35.34 | 65,613 | $12,467,126 |
| Moderna, Inc.-swap-jnst-l | 60770K107-TRS-05/31/33-L-MRNX | $190.01 | 33.98 | 63,083 | $11,986,401 |
| Moderna Inc Swap Marex-l | 60770K107-TRS-02/04/29-L-MRNX | $190.01 | 33.42 | 62,053 | $11,790,691 |
| Moderna Inc Swap Cf-l | 60770K107-TRS-09/08/28-L-MRNX | $190.01 | 32.10 | 59,601 | $11,324,786 |
| Moderna Inc Swap Nomura-l | 60770K107-TRS-03/31/33-L-MRNX | $190.01 | 31.06 | 57,661 | $10,956,167 |
| Moderna, Inc.-swap-nbcb-l | 60770K107-TRS-01/31/33-L-MRNX | $190.01 | 29.88 | 55,481 | $10,541,945 |
| United States Treasury Bill 11/19/2026 | 912797UZ8 | $99.51 | 24.96 | 8,850,000 | $8,806,815 |
| First American Government Obligations Fund 12/01/2031 | FGXXX | $100.00 | 6.65 | 2,345,404 | $2,345,404 |
| Moderna, Inc.-swap-bmob-l | 60770K107-TRS-08/31/28-L-MRNX | $190.01 | 4.05 | 7,517 | $1,428,305 |
| Cash & Other | Cash&Other | $1.00 | -131.50 | -46,387,254 | $-46,387,254 |
Distributions
Declaration Date |
Ex-Div Date |
Record Date |
Payable Date |
Amount ($) |
|---|---|---|---|---|
12/29/2026 |
12/30/2026 |
12/30/2026 |
12/31/2026 |
$– |